Thomas Newman, MD, MPH

Pediatrician

Dr. Thomas B. Newman is a pediatrician who cares for newborns.

Newman's research uses methods of epidemiology to study health problems in children, such as jaundice and infections in newborns, urinary tract infections and childhood lipid screening. He also teaches clinical research methods and is co-author of two textbooks, Designing Clinical Research and Evidence-Based Diagnosis.

Newman earned his medical degree from the University of California, San Diego School of Medicine. At UCSF, he completed a residency in pediatrics and a fellowship in clinical epidemiology, which included a master of public health degree, with a focus on epidemiology, at the University of California, Berkeley.

Newman is a fellow of the American Academy of Pediatrics and a member of the Union of Concerned Scientists, Physicians for Social Responsibility, Academic Pediatrics Association, Physicians for Human Rights, California Physicians Alliance, Physicians for a National Health Program, Evidence-Based Medicine Working Group, Society for Epidemiologic Research and Society for Medical Decision Making. He is passionate about environmental sustainability, and his work was recognized in 2011 when he received the first annual UCSF Faculty Sustainability Award.

More about Thomas Newman

Additional Languages

German
Spanish

Education

UC San Diego School of Medicine 1980
UC Berkeley, MPH, Epidemiology 1984

Residencies

UCSF, Pediatrics 1983

Fellowships

UCSF and UC Berkeley, Clinical Epidemiology 1985

Selected Research and Publications

  1. Coon ER, Newman TB, Hall M, Wilkes J, Bratton SL, Schroeder AR. Trends in Imaging Findings, Interventions, and Outcomes Among Children With Isolated Head Trauma. Pediatr Emerg Care. 2018 Apr 24.
  2. Wickremasinghe AC, Kuzniewicz MW, McCulloch CE, Newman TB. Efficacy of Subthreshold Newborn Phototherapy During the Birth Hospitalization in Preventing Readmission for Phototherapy. JAMA Pediatr. 2018 Apr 01; 172(4):378-385.
  3. Schroeder AR, Newman TB. Randomized Trials in Children With UTI. Pediatrics. 2017 Dec; 140(6).
  4. Kuzniewicz MW, Puopolo KM, Fischer A, Walsh EM, Li S, Newman TB, Kipnis P, Escobar GJ. A Quantitative, Risk-Based Approach to the Management of Neonatal Early-Onset Sepsis. JAMA Pediatr. 2017 Apr 01; 171(4):365-371.
  5. Slaughter JL, Reagan PB, Newman TB, Klebanoff MA. Comparative Effectiveness of Nonsteroidal Anti-inflammatory Drug Treatment vs No Treatment for Patent Ductus Arteriosus in Preterm Infants. JAMA Pediatr. 2017 Mar 06; 171(3):e164354.
  6. Chang PW, Kuzniewicz MW, McCulloch CE, Newman TB. A Clinical Prediction Rule for Rebound Hyperbilirubinemia Following Inpatient Phototherapy. Pediatrics. 2017 Mar; 139(3).
  7. Pletcher MJ, Pignone M, Jarmul JA, Moran AE, Vittinghoff E, Newman T. Population Impact & Efficiency of Benefit-Targeted Versus Risk-Targeted Statin Prescribing for Primary Prevention of Cardiovascular Disease. J Am Heart Assoc. 2017 Feb 10; 6(2).
  8. Teherani A, Nishimura H, Apatira L, Newman T, Ryan S. Identification of core objectives for teaching sustainable healthcare education. Med Educ Online. 2017; 22(1):1386042.
  9. Schroeder AR, Newman TB. US Preventive Task Force cites insufficient evidence for pediatric lipid screening. J Pediatr. 2017 Jan; 180:291-294.
  10. Chang PW, Newman TB, Maisels MJ. Update on Predicting Severe Hyperbilirubinemia and Bilirubin Neurotoxicity Risks in Neonates. Curr Pediatr Rev. 2017; 13(3):181-187.
  11. Newman TB, Wickremasinghe AC, Walsh EM, Grimes BA, McCulloch CE, Kuzniewicz MW. Phototherapy and Risk of Type 1 Diabetes. Pediatrics. 2016 Nov; 138(5).
  12. Newman TB, Schroeder AR, Pletcher MJ. Lipid Screening in Children: Low-Value Care. JAMA Intern Med. 2016 Oct 01; 176(10):1437-1438.
  13. Wu YW, Kuzniewicz MW, Croen L, Walsh EM, McCulloch CE, Newman TB. Risk of Autism Associated With Hyperbilirubinemia and Phototherapy. Pediatrics. 2016 Oct; 138(4).
  14. Kuzniewicz MW, Greene DN, Walsh EM, McCulloch CE, Newman TB. Association Between Laboratory Calibration of a Serum Bilirubin Assay, Neonatal Bilirubin Levels, and Phototherapy Use. JAMA Pediatr. 2016 Jun 01; 170(6):557-61.
  15. Wickremasinghe AC, Kuzniewicz MW, Grimes BA, McCulloch CE, Newman TB. Neonatal Phototherapy and Infantile Cancer. Pediatrics. 2016 Jun; 137(6).
  16. Newman TB, Wickremasinghe AC, Walsh EM, Grimes BA, McCulloch CE, Kuzniewicz MW. Retrospective Cohort Study of Phototherapy and Childhood Cancer in Northern California. Pediatrics. 2016 Jun; 137(6).
  17. Slaughter JL, Reagan PB, Bapat RV, Newman TB, Klebanoff MA. Nonsteroidal anti-inflammatory administration and patent ductus arteriosus ligation, a survey of practice preferences at US children's hospitals. Eur J Pediatr. 2016 Jun; 175(6):775-83.
  18. Martin MJ, Thottathil SE, Newman TB. Antibiotics Overuse in Animal Agriculture: A Call to Action for Health Care Providers. Am J Public Health. 2015 Dec; 105(12):2409-10.
  19. Wickremasinghe AC, Risley RJ, Kuzniewicz MW, Wu YW, Walsh EM, Wi S, McCulloch CE, Newman TB. Risk of Sensorineural Hearing Loss and Bilirubin Exchange Transfusion Thresholds. Pediatrics. 2015 Sep; 136(3):505-12.
  20. Wu YW, Kuzniewicz MW, Wickremasinghe AC, Walsh EM, Wi S, McCulloch CE, Newman TB. Risk for cerebral palsy in infants with total serum bilirubin levels at or above the exchange transfusion threshold: a population-based study. JAMA Pediatr. 2015 Mar; 169(3):239-46.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.